8.50
Mimedx Group Inc stock is traded at $8.50, with a volume of 189.58K.
It is up +0.00% in the last 24 hours and down -3.41% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$8.50
Open:
$8.46
24h Volume:
189.58K
Relative Volume:
0.24
Market Cap:
$1.25B
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
13.83
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
-2.30%
1M Performance:
-3.41%
6M Performance:
+35.57%
1Y Performance:
+9.68%
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
6.49 | 0 | 0 | 0 | 0 | 0.00 | |
![]()
PSNYW
Polestar Automotive Holding Uk
|
0.1945 | 443.17M | 2.07B | -1.42B | -1.37B | -0.6765 |
![]()
GOODO
Gladstone Commercial Corporation
|
20.70 | 372.90M | 0 | 0 | 0 | 0.00 |
![]()
MOBBW
Mobilicom Limited Warrants
|
0.4356 | 278.60M | 0 | 0 | 0 | 0.00 |
![]()
SHMD
Schmid Group N V
|
2.18 | 89.14M | 0 | 0 | 0 | 0.00 |
![]()
JUNE
Dhandho Junoon Etf
|
4.03 | 48.39M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
Mar-07-24 | Initiated | Lake Street | Buy |
Oct-27-23 | Initiated | Craig Hallum | Buy |
Oct-13-22 | Initiated | Mizuho | Buy |
Jul-26-21 | Initiated | Northland Capital | Outperform |
Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
Insiders At MiMedx Group Sold US$659k In Stock, Alluding To Potential Weakness - Simply Wall St
MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26 - GlobeNewswire
MIMEDX Q4 2024 Earnings Call: Key Financial Results Coming February 26What to Watch - StockTitan
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Sold by Chicago Capital LLC - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Purchased by SG Americas Securities LLC - MarketBeat
MiMedx Group (NASDAQ:MDXG) Shares Up 5.8%Time to Buy? - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Receives $12.00 Consensus Price Target from Analysts - Defense World
MiMedx Group, Inc. to Host Earnings Call - ACCESS Newswire
(MDXG) Proactive Strategies - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Given Average Rating of "Buy" by Brokerages - MarketBeat
JPMorgan Chase & Co. Acquires 215,995 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
JPMorgan Chase & Co. Buys 215,995 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group, Inc.'s (NASDAQ:MDXG) one-year returns climbed after last week's 6.2% gain, institutional investors must be happy - Simply Wall St
Cantor Fitzgerald Predicts MiMedx Group FY2025 Earnings - MarketBeat
MiMedx Group Updates Investor Presentation in Recent 8-K Filing - Defense World
Learn to Evaluate (MDXG) using the Charts - Stock Traders Daily
Barclays PLC Buys 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Barclays PLC Purchases 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
Tendonitis Pipeline Insights 2024: Therapies, Clinical Trials, MOA, ROA, and Developments | MetrioPharm, MiMedX group, InGeneron, Novartis, R3 Stem Cell - Barchart
MiMedx Group, Inc.'s (NASDAQ:MDXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
Principal Financial Group Inc. Purchases 3,292 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
(MDXG) Trading Report - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Receives $12.00 Consensus Target Price from Analysts - Defense World
MiMedx Group, Inc. (NASDAQ:MDXG) Given Average Recommendation of "Buy" by Analysts - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Geode Capital Management LLC - Defense World
Northland Capmk Predicts MiMedx Group Q1 Earnings - MarketBeat
Northland Capmk Forecasts MiMedx Group Q1 Earnings - Defense World
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Barclays PLC - Defense World
Barclays PLC Has $1.55 Million Stake in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
How the (MDXG) price action is used to our Advantage - Stock Traders Daily
Jane Street Group LLC Grows Position in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Jane Street Group LLC - Defense World
We Think MiMedx Group (NASDAQ:MDXG) Can Manage Its Debt With Ease - Simply Wall St
State Street Corp Lowers Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
State Street Corp Has $22.81 Million Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Fmr LLC - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 33,241 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
MIMEDX Group's SWOT analysis: wound care firm's stock faces market headwinds - Investing.com
MIMEDX Files Patent Infringement Lawsuit Against Surgenex - GlobeNewswire
MiMedx Group (MDXG) Files Patent Infringement Lawsuit Against Surgenex - StreetInsider.com
MIMEDX Battles Patent Infringement: Files Major Lawsuit Over Placental Allograft Technology - StockTitan
MiMedx extends corporate HQ lease, ensures director indemnification - Investing.com
MiMedx extends corporate HQ lease, ensures director indemnification By Investing.com - Investing.com UK
The Manufacturers Life Insurance Company Raises Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
(MDXG) On The My Stocks Page - Stock Traders Daily
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE P - The Eastern Progress Online
MIMEDX Group's SWOT analysis: wound care firm's stock faces growth hurdles - Investing.com Nigeria
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mimedx Group Inc Stock (MDXG) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Hulse William Frank IV | General Counsel and CAO |
Mar 13 '24 |
Sale |
7.95 |
20,381 |
162,029 |
479,959 |
Whitlow Ricci S | Chief Operating Officer |
Feb 16 '24 |
Sale |
8.07 |
15,493 |
125,075 |
416,321 |
Whitlow Ricci S | Chief Operating Officer |
Feb 20 '24 |
Sale |
8.01 |
15,271 |
122,351 |
401,050 |
Whitlow Ricci S | Chief Operating Officer |
Feb 14 '24 |
Sale |
8.03 |
15,845 |
127,267 |
447,012 |
Whitlow Ricci S | Chief Operating Officer |
Feb 15 '24 |
Sale |
8.06 |
15,198 |
122,496 |
431,814 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):